Centre Urges States/UTs to Ensure Prominent Display of Healthcare Service Rates at Clinical Establishments

1. At a Glance

• On 12 October 2026 the Union Ministry of Health and Family Welfare (MoHFW) asked all States and UTs to make sure Clinical Establishments display the rates they charge for services and facilities prominently. [1]
• The legal basis is the Clinical Establishments (Registration and Regulation) Act, 2010 and the Clinical Establishments (Central Government) Rules, 2012. Rule 9(i) requires hospitals to display their rates "at a conspicuous place in the local as well as in English language". [1][4]
• For UPSC this topic covers several themes at once:
• Health federalism: health is a State subject. [1]
• Patient rights and price transparency.
• The Supreme Court's scrutiny of the Centre's failure to set a "range of rates". [4]
• Medical value travel on Medical and Ayush Visas. [1][5]

2. Why in the News

• 12 Oct 2026: Union Health Secretary Smt. Punya Salila Srivastava wrote to the Chief Secretaries of all States/UTs. She asked them to review compliance and issue advisories so that rates are displayed at "conspicuous, clearly visible and easily accessible locations". [1]
• The letter also asks States to encourage the display of package rates for foreign patients who come to India on Medical or Ayush Visas. [1]
• The Health Secretary asked the Chief Secretaries to give the matter their personal attention. [1]

3. Background & Evolution

• 15 Apr 2010: The Bill was introduced in the Lok Sabha by Health Minister Ghulam Nabi Azad. [3]
• 3 May 2010: The Lok Sabha passed the Bill. [3]
• 18 Aug 2010: The Act was enacted. [2]
• 18 Sep 2010: The Act came into force in Arunachal Pradesh, Himachal Pradesh, Mizoram, Sikkim and all UTs. Other States can apply it by passing a resolution to adopt it. [2][3]
• 2012: The Clinical Establishments (Central Government) Rules were notified. Rule 9 sets the "other conditions for registration and continuation", including rate display and a range of rates. [4]
• 3 Nov 2022: In Veterans Forum for Transparency in Public Life v. Union of India, W.P.(C) 648/2020, a bench of Justices S.K. Kaul and A.S. Oka made three points: [4]
• It held that the Central Government has the responsibility to fix the range of rates, even though States implement the rules.
• It ordered the Centre to file an affidavit within 4 weeks.

• It imposed costs of ₹20,000.

• 2026: The Act was amended by the Jan Vishwas (Amendment of Provisions) Act, 2026 (8 of 2026). [2]

• 12 Oct 2026: MoHFW issued the advisory on rate display (this news hook). [1]

4. Core Static Facts

Item	Fact
Parent ministry	Ministry of Health and Family Welfare [1][3]
Statute	Clinical Establishments (Registration and Regulation) Act, 2010 [1][2]
Rules	Clinical Establishments (Central Government) Rules, 2012 [1][4]
Rule 9(i)	Display rates for each type of service and facility at a conspicuous place, in the local language and English [4]
Rule 9(ii)	Charge within the range of rates set by the Central Government in consultation with State Governments [4]
Rule 9(iii)	Comply with Standard Treatment Guidelines [4]
Rule 9(iv)	Maintain Electronic Medical Records / Electronic Health Records (EMR/EHR) for every patient [4]
Rule 9(v)	Maintain information and statistics as required by other applicable laws [4]
Original applicability	Arunachal Pradesh, Himachal Pradesh, Mizoram, Sikkim and all UTs; other States join by resolution [2][3]
Exclusion	Establishments owned or managed by the Armed Forces [3]
National Council of Clinical Establishments	Chaired by the DGHS with 22 other members. Sets minimum standards, classifies establishments and keeps the national register [3]
District Registering Authority	Chaired by the District Collector; includes the District Health Officer and 3 other members [3]
Registration validity	Provisional: 1 year. Permanent: 5 years. Renewal application due 6 months before expiry [3]
Non-adopting States	Governed by their own State/UT laws, many of which also require rate display [1]

5. Multi-Dimensional Analysis

Administrative / Federal

• Health is a State subject, so the Centre can only advise. Implementation and enforcement rest with the States and UTs. [1]
• The rules apply in two layers: the Central Act and Rules where adopted, and State laws elsewhere. Standards therefore differ across States. [1][2]
• In its 2022 order the SC separated the Centre's duty to fix the range of rates from the States' duty to implement the rules. [4]

Legal / Constitutional

• Rate display is a condition for registration and continuation, not just guidance. Non-compliance can affect an establishment's registration. [4]
• The petition before the Supreme Court sought one thing: that the Centre set the fee chargeable under Rule 9. [4]
• Adoption by State resolution is the Article 252 route, which lets Parliament legislate on a State-List subject for States that consent. (Analytical inference; not confirmed from a whitelisted source.)

Ethical / Governance

• Transparency helps patients make informed decisions, plan their spending and avoid billing disputes. It also builds trust in the system. [1]
• This is the "information asymmetry" problem in healthcare markets, which is useful material for GS-IV and GS-II.

Economic

• Knowing likely costs lets families plan medical expenditure. [1] This links to the out-of-pocket expenditure (OOPE) debate.
• Transparent package rates support India's position as a trusted destination for medical and Ayush care. [1]

Social

• Displays must be in the local language, which helps patients and attendants who do not read English. [1][4]

Geopolitical / Soft power

• Transparent pricing for Medical and Ayush Visa holders supports medical value travel. PIB names the AYUSH Visa and Regional Medical Hubs as parts of this ecosystem. [1][5]

6. Recent Developments (last 12–18 months)

• May 2026: A PIB document on medical and wellness tourism describes India as a hub for medical value travel, citing the AYUSH Visa. [5]
• 2026: The Jan Vishwas (Amendment of Provisions) Act, 2026 was listed as an amending law of the CE Act. [2]
• 12 Oct 2026: The Union Health Secretary wrote to the Chief Secretaries on rate display and on package rates for international patients. [1]

7. Prelims Hooks

• The rate-display duty comes from Rule 9(i) of the CE (Central Government) Rules, 2012, not from the Act itself. [4]
• Rates must be displayed in both the local language and English. [1][4]
• Under Rule 9(ii), the Central Government, in consultation with States, sets the range of rates. [4]
• Rule 9 also requires compliance with Standard Treatment Guidelines and maintenance of EMR/EHR. [4]
• The Act came into force on 18 Sep 2010 in Arunachal Pradesh, Himachal Pradesh, Mizoram, Sikkim and the UTs. [2]
• Other States apply the Act by passing a resolution to adopt it. [2]
• The National Council of Clinical Establishments is chaired by the DGHS. [3]
• The District Registering Authority is chaired by the District Collector. [3]
• Permanent registration is valid for 5 years; provisional registration for 1 year. [3]
• Armed Forces establishments are excluded. [3]
• The PIL is Veterans Forum for Transparency in Public Life v. UoI, W.P.(C) 648/2020. [4]
• The Oct 2026 letter came from the Union Health Secretary, addressed to Chief Secretaries. [1]
• The advisory specifically covers foreigners on Medical and Ayush Visas. [1]
• The Act was amended by the Jan Vishwas (Amendment of Provisions) Act, 2026. [2]

8. Showing a Price Is Not the Same as Controlling It

• The advisory only asks hospitals to show a price. It does not cap the price.
• Rule 9(i) asks hospitals to display their rates. Rule 9(ii) asks them to charge within a range of rates set by the Centre [4].
• The October 2026 letter pushes only the first duty, the display [1].

• So a hospital can put up a very high rate and still be fully compliant.

• A rate board helps only a patient who has time to compare hospitals

• Price transparency (making prices public so buyers can compare) works when the buyer can walk away and choose another seller.
• A heart-attack or accident patient cannot do that. The family goes to the nearest hospital and agrees to whatever it charges.

• This is information asymmetry (the hospital knows far more than the patient): the doctor decides both what the patient needs and what it will cost.

• The final bill often grows beyond the displayed rate

• Under PM-JAY (Ayushman Bharat's insurance scheme for poor families), the government had to separate costly drugs, consumables (single-use items like stents and syringes) and diagnostic tests from the per-day bed rate in its package prices [10].

• A hospital rate board that lists only room and procedure charges does not show these extra items. They are often where the bill goes up.

• Who needs it most is still paying from their own pocket

• Out-of-pocket expenditure (OOPE: money families pay directly at the time of treatment) was 62.6% of total health spending in 2014-15 and 47.1% in 2019-20 [7].
• It fell to 39.4% in 2021-22 [8]. Even at that level, families pay about two of every five rupees spent on health.
• For them a displayed price helps only a little. What they need is a limit on the price.

9. Why the Centre Has Still Not Fixed a Price Range

• The duty has been on paper since 2012
• The 2012 Rules made the Central Government responsible for setting a range of rates, in consultation with States [4].

• In an earlier reply to Parliament, the government said a subcommittee of the National Council for Clinical Establishments had been set up to define this range of rates [6].

• No final range had come out by 2022, so the Supreme Court stepped in

• In 2022 the Court held that fixing the range is the Centre's job, even though States implement the rules. It also imposed ₹20,000 costs [4].

• The Centre's own position is that implementing and monitoring the Act is the work of the States and UTs [6]. The Court did not accept this as a reason for the Centre to stop setting the rates.

• The 2026 advisory does the easy part and leaves the hard part

• Asking States to enforce display costs the Centre nothing and upsets no one [1].
• Setting a price range means arguing with private hospitals over each procedure. That is the step that has been pending for over a decade.

10. The Hospitals' Side: One Price Range Cannot Fit Every Hospital

• The strongest objection
• A bypass surgery costs a hospital different amounts in a metro and in a small town. It also depends on equipment, staff and quality level, for example NABH (the national hospital quality certification) versus no accreditation.

• If the range is set too low, hospitals may cut quality, refuse complex cases or stop investing in new beds.

• What this argument gets right

• A single national price really would be unfair. Government package rates have had to be raised over time: under PM-JAY's Health Benefit Package 2022, rates for 832 procedures were increased [10].

• That shows a fixed rate goes out of date quickly unless someone keeps revising it.

• Where the argument fails

• Rule 9(ii) asks for a range, not one price [4]. A range can have separate bands for city type and hospital grade.
• India already has a working price list. PM-JAY sets package rates for procedures and revises them [10]. So the claim that "pricing care is impossible" does not hold.
• The real choice is not between a price range and freedom. It is between a range that is revised regularly and the current state, where there is no range at all.

11. Why the Rule Does Not Reach Most Patients

• The Central Rules bind only States that adopted the Central Act
• Other States follow their own laws, which may define rate display and enforcement differently [1][2].
• Large States still prefer their own laws. Maharashtra has brought its own Clinical Establishments (Registration and Regulation) Bill, 2026 [9].

• So the Rule 9(ii) price range, once it exists, would not bind hospitals in such States automatically.

• The letter can only ask. It cannot penalise

• Because health is a State subject (under the Seventh Schedule, States make laws on it), the Centre can only write to Chief Secretaries and request their "personal attention" [1].
• Whether a hospital that hides its rate board loses its registration depends on each district authority acting on it.

12. What Should Happen Next

• MoHFW and the National Council should notify the range of rates, starting from PM-JAY prices
• The subcommittee meant to define the range already exists [6].
• PM-JAY's package list already prices procedures and is revised from time to time [10]. Using it as the base saves years of fresh costing.

• Bands by city type and hospital grade would answer the hospitals' main objection.

• States should make the display rule cover the full bill, not only room rent

• The rate list should name the separate charges for drugs, consumables and tests, the same items PM-JAY had to separate from its packages [10].

• District Registering Authorities should check rate boards during registration renewal, because display is already a condition of registration [4].

• States that run their own laws should copy Rule 9's display and price-range duties

• States drafting new laws, such as Maharashtra in 2026 [9], can include both duties from the start. Otherwise the patchwork across States continues.

13. Anchors for Answers

• Data: OOPE fell from 62.6% of total health spending (2014-15) to 47.1% (2019-20) [7], and to 39.4% in 2021-22 [8]
• Data: Rates for 832 procedures were raised under PM-JAY Health Benefit Package 2022 [10]
• Report/Committee: Subcommittee of the National Council for Clinical Establishments to define the range of rates [6]
• Law/Case: Rule 9(i) and 9(ii), Clinical Establishments (Central Government) Rules, 2012; Veterans Forum for Transparency in Public Life v. Union of India (SC, 2022), which held that fixing the range of rates is the Centre's duty and imposed ₹20,000 costs [4]
• Comparison: Maharashtra's own Clinical Establishments Bill, 2026, compared with the Central Act's adoption route [9]
• Scheme: Ayushman Bharat PM-JAY Health Benefit Packages, a ready government price list that could anchor the Rule 9(ii) range [10]

14. Mains Relevance

• GS-II: "Issues relating to development and management of Social Sector/Services relating to Health"; "Federalism"; "Transparency and accountability"; "Role of the Judiciary".
• GS-III: Medical value travel and services-sector growth.
• GS-IV: Ethics in private healthcare; information asymmetry.
• Possible question stems: 1. Health is a State subject, yet patient protection demands national standards. Critically examine the working of the Clinical Establishments Act, 2010 in this light. 2. Price transparency alone cannot curb exploitative billing in private hospitals. Discuss with reference to Rule 9 of the Clinical Establishments Rules, 2012 and judicial interventions. 3. Examine the role of regulatory transparency in positioning India as a global destination for medical and Ayush value travel.

15. Related Topics to Study Next

• Charter of Patients' Rights (NHRC): rate transparency is one of its core patient rights.
• Article 252 and the 7th Schedule (Entry 6, List II): explains why the Act applies only where adopted.
• Ayushman Bharat PM-JAY package rates: the State's existing benchmark for procedure pricing.
• CGHS rates: discussed as a possible benchmark in the range-of-rates debate.
• Ayush Visa and Medical Visa / Heal in India: the international-patient angle of the advisory. [5]
• NABH accreditation: quality standards complement price standards.
• Jan Vishwas Acts (2023, 2026): decriminalisation of offences, including amendments to the CE Act. [2]
• National Health Policy 2017 / OOPE trends: why price transparency matters financially.

16. NCERT Concepts to Revise

• Asymmetric information (Economy): Hospitals know far more than patients about needs and costs; rate display tries to reduce this gap.
• Legislation by consent of states (Polity): Explains why the Central Act applies only to states that adopt it by resolution.
• State List (Polity): Public health is a State subject, so the Centre can only advise states.
• Federalism (Polity): Centre-state division of powers explains why enforcement is left to states and standards differ.
• Transparency (Polity): Core idea behind rate display: openness so citizens can examine and compare what they are charged.
• Health expenditure (Economy): Links rate display to out-of-pocket health spending and why families need cost certainty.

17. Common Errors / Trap Areas

• Act vs Rules: the display duty is in Rule 9 of the 2012 Rules, not a section of the 2010 Act. [4]
• Display vs range of rates: Rule 9(i) covers display, which is the subject of this advisory. Rule 9(ii) covers the range of rates, which was the issue in the SC case. [4]
• Original applicability: the Act covers 4 States plus all UTs (Arunachal Pradesh, Himachal Pradesh, Mizoram, Sikkim). Do not assume it applies across India. [2][3]
• Who chairs what: the National Council is chaired by the DGHS, not the Health Minister. District authorities are chaired by the Collector. [3]
• Advisory, not a directive: the Centre has "urged" States, and enforcement lies with the States. [1]
• Number of adopting States: secondary reports give conflicting figures, so check an official source before using any number.